ProfileGDS4718 / 207405_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 80% 81% 84% 82% 86% 81% 86% 83% 82% 84% 86% 83% 82% 82% 84% 83% 87% 81% 87% 73% 82% 83% 84% 83% 84% 84% 85% 85% 80% 84% 86% 84% 81% 84% 85% 90% 79% 80% 84% 85% 86% 84% 83% 84% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.9021580
GSM549102patient 115, normal, homogenized [OPG study]7.8593681
GSM549104patient 119, normal, homogenized [OPG study]8.3717184
GSM549108patient 138, normal, homogenized [OPG study]7.9262382
GSM549119patient 077, normal, homogenized [OPG study]8.5880586
GSM549133patient 032, cancer, homogenized [OPG study]8.1546281
GSM549139patient 042, cancer, homogenized [OPG study]8.6647486
GSM549099patient 107, normal, homogenized [OPG study]8.1588183
GSM549109patient 139, normal, homogenized [OPG study]8.0434782
GSM549110patient 046, normal, homogenized [OPG study]8.2998184
GSM549114patient 063, normal, homogenized [OPG study]8.7103886
GSM549122patient 082, normal, homogenized [OPG study]8.264583
GSM549134patient 033, cancer, homogenized [OPG study]8.1731982
GSM549136patient 036, cancer, homogenized [OPG study]8.1953282
GSM549140patient 044, cancer, homogenized [OPG study]8.4654684
GSM549111patient 047, normal, homogenized [OPG study]8.2807583
GSM549113patient 057, normal, homogenized [OPG study]8.8549687
GSM549132patient 031, cancer, homogenized [OPG study]7.9683281
GSM549137patient 038, cancer, homogenized [OPG study]8.6652687
GSM549142patient 047, cancer, homogenized [OPG study]7.0550673
GSM549100patient 110, normal, homogenized [OPG study]8.0277782
GSM549107patient 135, normal, homogenized [OPG study]8.2971883
GSM549115patient 068, normal, homogenized [OPG study]8.5594284
GSM549116patient 072, normal, homogenized [OPG study]8.2536583
GSM549120patient 078, normal, homogenized [OPG study]8.375684
GSM549131patient 030, cancer, homogenized [OPG study]8.398584
GSM549118patient 074, normal, homogenized [OPG study]8.4460285
GSM549129patient 027, cancer, homogenized [OPG study]8.4713485
GSM549123patient 088, normal, homogenized [OPG study]7.8417580
GSM549124patient 006, cancer, homogenized [OPG study]8.2613484
GSM549126patient 015, cancer, homogenized [OPG study]8.5299186
GSM549128patient 025, cancer, homogenized [OPG study]8.3443384
GSM549103patient 117, normal, homogenized [OPG study]7.7870781
GSM549117patient 073, normal, homogenized [OPG study]8.4664584
GSM549138patient 041, cancer, homogenized [OPG study]8.5292685
GSM549141patient 045, cancer, homogenized [OPG study]9.2626790
GSM549130patient 028, cancer, homogenized [OPG study]7.7493479
GSM549101patient 111, normal, homogenized [OPG study]7.817880
GSM549105patient 128, normal, homogenized [OPG study]8.2718284
GSM549106patient 134, normal, homogenized [OPG study]8.6016485
GSM549112patient 048, normal, homogenized [OPG study]8.6208786
GSM549125patient 011, cancer, homogenized [OPG study]8.2945584
GSM549127patient 024, cancer, homogenized [OPG study]8.1816583
GSM549135patient 035, cancer, homogenized [OPG study]8.4332484